SBC Medical Group Holdings Incorporated (SBC)
NASDAQ: SBC · Real-Time Price · USD
3.380
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
3.380
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:10 PM EDT
SBC Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SBC stock has a target of 8.00, which predicts an increase of 136.69% from the current stock price of 3.38.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 6, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for SBC is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Initiates $8 | Strong Buy | Initiates | $8 | +136.69% | Mar 6, 2026 |
Financial Forecast
Revenue This Year
181.17M
from 173.61M
Increased by 4.36%
Revenue Next Year
196.89M
from 181.17M
Increased by 8.68%
EPS This Year
0.44
from 0.50
Decreased by -10.90%
EPS Next Year
0.49
from 0.44
Increased by 12.21%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 191.2M | 210.3M | |
| Avg | 181.2M | 196.9M | |
| Low | 170.4M | 182.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 10.1% | 16.1% | |
| Avg | 4.4% | 8.7% | |
| Low | -1.8% | 0.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.49 | 0.55 | |
| Avg | 0.44 | 0.49 | |
| Low | 0.39 | 0.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.3% | 23.8% | |
| Avg | -10.9% | 12.2% | |
| Low | -20.8% | 4.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.